HOWARD E GENDELMAN, MD
Osteopathic Medicine at Nebraska Medical Ctr, Omaha, NE
License number
Nebraska 19026
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
988102 Nebraska Medical Ctr, Omaha, NE 68198
Phone
(402) 559-4015
(402) 559-8715 (Fax)
(402) 559-8715 (Fax)
Personal information
See more information about HOWARD E GENDELMAN at radaris.comName
Address
Phone
125 127Th Plz, Omaha, NE 68154
Organization information
See more information about HOWARD E GENDELMAN at bizstanding.comUniversity Of Nebraska Medical Center - Howard E Gendelman MD
985880 Nebraska Medical Ctr, Omaha, NE 68198
Categories:
Ergonomics Research & Development, Infectious Disease Physicians & Surgeons, Internal Medicine Physicians & Surgeons
Site:
Phone:
(402) 559-8910 (Phone)
Professional information
Professor At University Of Nebraska Medical Center
Position:
Professor at University of Nebraska Medical Center, Professor and Chair at The Nebraska Medical Center
Location:
Greater Omaha Area
Industry:
Biotechnology
Work:
University of Nebraska Medical Center
-
Professor
The Nebraska Medical Center
since 2004
-
Professor and Chair
Howard Eliot Gendelman, Omaha NE
Specialties:
Internist
Address:
4400 Emile St, Omaha, NE 68198
988102 Nebraska Medical Ctr, Omaha, NE 68198
Omaha, NE 68198
988102 Nebraska Medical Ctr, Omaha, NE 68198
Omaha, NE 68198
Education:
Pennsylvania State University, College of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Infectious Disease (Internal Medicine)
Johns Hopkins Hospital - Fellowship - Infectious Disease (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Professor And Chair At University Of Nebraska Medical Center
Position:
Professor and Chair at University of Nebraska Medical Center
Location:
Greater Omaha Area
Industry:
Biotechnology
Work:
University of Nebraska Medical Center
-
Professor and Chair
Education:
Pennsylvania State University College of Medicine 1975 - 1979
Dr. Howard E Gendelman - MD (Doctor of Medicine)
Hospitals:
UNMC Pharmacology/Nueroscnc
550 S 45Th St, Omaha 68198
University Nebraska Med Ctr INF
985400 Nebraska Medical Ctr, Omaha 68198
UNMC Pharmacology/Nueroscnc
550 S 45Th St, Omaha 68198
University Nebraska Med Ctr INF
985400 Nebraska Medical Ctr, Omaha 68198
550 S 45Th St, Omaha 68198
University Nebraska Med Ctr INF
985400 Nebraska Medical Ctr, Omaha 68198
UNMC Pharmacology/Nueroscnc
550 S 45Th St, Omaha 68198
University Nebraska Med Ctr INF
985400 Nebraska Medical Ctr, Omaha 68198
Education:
Medical Schools
Pennsylvania State University / College of Medicine
Graduated: 1979
Pennsylvania State University / College of Medicine
Graduated: 1979
Method For Delivering Particulate Drugs To Tissues
US Patent:
2006028, Dec 14, 2006
Filed:
Apr 19, 2006
Appl. No.:
11/406986
Inventors:
Barrett Rabinow - Skokie IL, US
Howard Gendelman - Omaha NE, US
James Kipp - Wauconda IL, US
Howard Gendelman - Omaha NE, US
James Kipp - Wauconda IL, US
International Classification:
G11B 27/00
US Classification:
386055000
Abstract:
The present invention is concerned with delivering a pharmaceutical composition to a tissue target of a mammalian subject for treating brain diseases or disorders. The process includes the steps of: (i) providing a dispersion of the pharmaceutical composition as particles having an average particle size of from about 150 nm to about 100 microns, and (ii) administering the dispersion to the mammalian subject for delivery to the tissue target of a portion of the pharmaceutical composition by cells capable of reaching the tissue target. The dispersion of the pharmaceutical composition as particles, for example, can be phagocytised or adsorbed by the cells prior or subsequent to administration into the mammalian subject. The dispersion of the pharmaceutical composition can be administered to the central nervous system or the vascular system. After administration, the loaded cells transport the pharmaceutical composition as particles into the tissue target.
Method For Delivering Drugs To The Brain
US Patent:
2005004, Mar 3, 2005
Filed:
Jun 15, 2004
Appl. No.:
10/868680
Inventors:
Barrett Rabinow - Skokie IL, US
James Kipp - Wauconda IL, US
Howard Gendelman - Omaha NE, US
James Kipp - Wauconda IL, US
Howard Gendelman - Omaha NE, US
International Classification:
A61L009/04, A61K009/14
US Classification:
424046000
Abstract:
The present invention is concerned with delivering a pharmaceutical composition to the brain of a mammalian subject for treating brain diseases or disorders. The process includes the steps of: (i) providing a dispersion of the pharmaceutical composition as particles having an average particle size of from about 150 nm to about 100 microns, and (ii) administering the dispersion to the mammalian subject for delivery to the brain of a portion of the pharmaceutical composition by cells capable of reaching the brain. The dispersion of the pharmaceutical composition as particles, for example, can be phagocytised or adsorbed by the cells prior or subsequent to administration into the mammalian subject. The dispersion of the pharmaceutical composition can be administered to the central nervous system or the vascular system. After administration, the loaded cells transport the pharmaceutical composition as particles into the brain.
Compositions And Methods For Drug Delivery
US Patent:
2009027, Nov 5, 2009
Filed:
Mar 5, 2009
Appl. No.:
12/398894
Inventors:
Arnaud Beduneau - Lincoln NE, US
Howard Gendelman - Omaha NE, US
Barrett Rabinow - Skokie IL, US
Jane Werling - Arlington Heights IL, US
Howard Gendelman - Omaha NE, US
Barrett Rabinow - Skokie IL, US
Jane Werling - Arlington Heights IL, US
Assignee:
BAXTER INTERNATIONAL INC. - Deerfield IL
BAXTER HEALTHCARE S.A. - Wallisellen
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA - Lincoln NE
BAXTER HEALTHCARE S.A. - Wallisellen
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA - Lincoln NE
International Classification:
A61K 9/50, B32B 5/16, C12N 5/06, A61P 35/00, A61P 25/28
US Classification:
424490, 428403, 435325
Abstract:
The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises an opsonin, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm.
Methods And Compositions For The Treatment Of Human Immunodeficiency Virus Infection
US Patent:
2002015, Oct 17, 2002
Filed:
Apr 6, 2001
Appl. No.:
09/828648
Inventors:
Tsuneya Ikezu - Omaha NE, US
Gary Leisman - Omaha NE, US
Kimberly Carlson - Omaha NE, US
Howard Gendelman - Omaha NE, US
Gary Leisman - Omaha NE, US
Kimberly Carlson - Omaha NE, US
Howard Gendelman - Omaha NE, US
International Classification:
A61K038/17, C12N009/50, C07H021/02, C12N005/06, C12P021/02, C12N015/867, A61K038/00, C07H021/04, A61K031/70, A01N043/04, C12P021/06, A61K039/21, C12N015/00, C12N015/09, C12N015/63, C12N015/70, C12N015/74, C12N005/00, C12N005/02, C07K016/00, C12P021/08
US Classification:
514/044000, 514/012000, 536/023720, 435/069100, 435/325000, 435/320100, 435/219000, 530/388260, 424/207100, 424/208100
Abstract:
Materials and methods are provided to inhibit HIV replication in targeted host cells.
Methods And Compositions For Inhibiting Diseases Of The Central Nervous System
US Patent:
8491890, Jul 23, 2013
Filed:
Jul 9, 2009
Appl. No.:
12/500414
Inventors:
Howard E. Gendelman - Omaha NE, US
R. Lee Mosley - Omaha NE, US
Ashley D. Reynolds - Omaha NE, US
R. Lee Mosley - Omaha NE, US
Ashley D. Reynolds - Omaha NE, US
Assignee:
Board of Regents of the University of Nebraska - Lincoln NE
International Classification:
A61K 38/44, A61K 38/00, A61P 25/00, C07K 14/47, A61K 38/48, A61K 39/00, A61K 47/42, C12Q 1/37, C12N 9/00, C12N 5/02, G01N 33/15, A61P 25/28, A61P 25/16
US Classification:
424 944, 4241851, 424 946, 435 4, 435183, 435325, 435375, 436 86, 436 89, 514 11, 514 177, 514 178, 514 179, 514772, 514773, 514 131
Abstract:
Methods and compositions for treating central nervous system diseases and disorders are disclosed.
Compositions For Protein Delivery And Methods Of Use Thereof
US Patent:
2010029, Nov 18, 2010
Filed:
May 9, 2008
Appl. No.:
12/599637
Inventors:
Alexander V. Kabanov - Omaha NE, US
Tatiana Bronich - Omaha NE, US
Elena Batrakova - Omaha NE, US
Howard Gendelman - Omaha NE, US
Tatiana Bronich - Omaha NE, US
Elena Batrakova - Omaha NE, US
Howard Gendelman - Omaha NE, US
International Classification:
A61K 38/02, A61K 35/12, A61K 38/43, A61K 39/395, A61K 38/22, A61K 38/18, A61K 38/44, A61K 38/46, A61K 35/28, C12N 5/071, C12N 5/078, C12N 5/0783, A61P 25/00
US Classification:
4241301, 514 177, 424 937, 424 941, 514 97, 514 83, 424 944, 424 946, 424 9371, 435366, 435372, 4353723
Abstract:
Compositions and methods for the delivery of a protein of interest are provided.